Skip to content

Browse grants
For nonprofits
For business
By state

Sign in Create account

Home
/
Grants
/
Mechanisms that Impact Cancer Risk with Use of Incretin…

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

National Institutes of Health

Deadline

January 7, 2027

Opens

November 18, 2024

Posted

November 18, 2024

Eligible locations

Nationwide

Opportunity number

PAR-25-070

Apply on Grants.gov

Applications are submitted on the federal site. FedGrantFinder is not affiliated with the U.S. government.

Every open federal grant, searchable by who you are and where you are. Updated nightly from Grants.gov.

Find funding

Browse all grants
Closing in 30 days
Grants by state
Grants by agency

Who you are

Nonprofits
Small business
Individuals
State & local government

Site

About
How it works
FAQ
Privacy
Terms

© 2026 FedGrantFinder. Not affiliated with the U.S. government.

Data from Grants.gov